Free Trial

The Pennant Group (NASDAQ:PNTG) Issues FY 2025 Earnings Guidance

The Pennant Group logo with Medical background

Key Points

  • The Pennant Group has provided its earnings guidance for FY 2025, projecting earnings per share between $1.090 and $1.150, slightly above the consensus estimate of $1.116.
  • Revenue guidance for the same period is set at $852.8 million to $887.6 million, exceeding the consensus revenue estimate of $852.1 million.
  • Wall Street has mixed ratings on PNTG stock, with an average target price of $33.80, where two analysts recommend holding and three suggest buying.
  • Want stock alerts on The Pennant Group? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

The Pennant Group (NASDAQ:PNTG - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 1.090-1.150 for the period, compared to the consensus earnings per share estimate of 1.116. The company issued revenue guidance of $852.8 million-$887.6 million, compared to the consensus revenue estimate of $852.1 million.

The Pennant Group Price Performance

PNTG stock traded up $1.88 during trading on Friday, hitting $26.00. 1,025,014 shares of the stock traded hands, compared to its average volume of 379,721. The Pennant Group has a one year low of $21.18 and a one year high of $37.13. The stock has a market cap of $898.56 million, a price-to-earnings ratio of 33.33, a P/E/G ratio of 2.21 and a beta of 1.48. The company has a 50 day simple moving average of $26.04 and a 200 day simple moving average of $26.00. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 0.11.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on PNTG shares. Wells Fargo & Company raised their price objective on shares of The Pennant Group from $30.00 to $31.00 and gave the company an "equal weight" rating in a research report on Tuesday, June 3rd. Wall Street Zen upgraded shares of The Pennant Group from a "hold" rating to a "buy" rating in a research report on Saturday. Stephens restated an "overweight" rating and issued a $35.00 price objective on shares of The Pennant Group in a research report on Tuesday, June 10th. Finally, Truist Financial lowered their price objective on shares of The Pennant Group from $32.00 to $28.00 and set a "hold" rating for the company in a research report on Wednesday, July 16th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, The Pennant Group has an average rating of "Moderate Buy" and an average price target of $33.80.

View Our Latest Research Report on The Pennant Group

Insiders Place Their Bets

In other news, Director Joanne Stringfield sold 5,000 shares of The Pennant Group stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $29.47, for a total transaction of $147,350.00. Following the completion of the sale, the director owned 30,275 shares in the company, valued at $892,204.25. The trade was a 14.17% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 5.40% of the company's stock.

Institutional Investors Weigh In On The Pennant Group

Several institutional investors have recently modified their holdings of PNTG. Royal Bank of Canada grew its holdings in The Pennant Group by 174.5% during the first quarter. Royal Bank of Canada now owns 27,290 shares of the company's stock valued at $687,000 after purchasing an additional 17,347 shares during the period. Jane Street Group LLC acquired a new position in The Pennant Group during the first quarter valued at approximately $297,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in The Pennant Group by 4.5% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 81,392 shares of the company's stock valued at $2,047,000 after purchasing an additional 3,507 shares during the period. AQR Capital Management LLC grew its holdings in The Pennant Group by 32.6% during the first quarter. AQR Capital Management LLC now owns 10,255 shares of the company's stock valued at $258,000 after purchasing an additional 2,524 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in The Pennant Group by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,394 shares of the company's stock valued at $488,000 after purchasing an additional 857 shares during the period. Institutional investors and hedge funds own 85.88% of the company's stock.

About The Pennant Group

(Get Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Featured Stories

Should You Invest $1,000 in The Pennant Group Right Now?

Before you consider The Pennant Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.

While The Pennant Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Growth Stocks That Could Pop Before Summer Ends
3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines